These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 189658

  • 1. Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients.
    Barndt R, Blankenhorn DH, Crawford DW, Brooks SH.
    Ann Intern Med; 1977 Feb; 86(2):139-46. PubMed ID: 189658
    [Abstract] [Full Text] [Related]

  • 2. Regression and progression of femoral atherosclerosis in human beings treated for hyperlipoproteinemia.
    Nutr Rev; 1977 May; 35(5):104-7. PubMed ID: 194177
    [No Abstract] [Full Text] [Related]

  • 3. The rate of atherosclerosis change during treatment of hyperlipoproteinemia.
    Blankenhorn DH, Brooks SH, Selzer RH, Barndt R.
    Circulation; 1978 Feb; 57(2):355-61. PubMed ID: 618626
    [Abstract] [Full Text] [Related]

  • 4. The effect of serum lipid regulation on the development of femoral atherosclerosis in hyperlipidaemia: a non-randomized controlled study.
    Olsson AG, Ruhn G, Erikson U.
    J Intern Med; 1990 Jun; 227(6):381-90. PubMed ID: 2351925
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of asymptomatic femoral artery atheromas in hyperlipoproteinemic patients.
    Barndt R, Blankenhorn DH, Crawford DW.
    Atherosclerosis; 1974 Jun; 20(2):253-62. PubMed ID: 4370281
    [No Abstract] [Full Text] [Related]

  • 6. Xanthomatosis and other clinical findings in patients with elevated levels of very low density lipoproteins.
    Vermeer BJ, van Gent CM, Goslings B, Polano MK.
    Br J Dermatol; 1979 Jun; 100(6):657-66. PubMed ID: 223620
    [Abstract] [Full Text] [Related]

  • 7. Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial.
    Duffield RG, Lewis B, Miller NE, Jamieson CW, Brunt JN, Colchester AC.
    Lancet; 1983 Sep 17; 2(8351):639-42. PubMed ID: 6136793
    [Abstract] [Full Text] [Related]

  • 8. Repeat femoral arteriography in hyperlipidemic patients. A study of progression and regression of atherosclerosis.
    Erikson U, Helmius G, Hemmingsson A, Ruhn G, Olsson AG.
    Acta Radiol; 1988 Sep 17; 29(3):303-9. PubMed ID: 2968099
    [Abstract] [Full Text] [Related]

  • 9. Type 4 hyperlipoproteinemia: one theory of atherogenesis.
    Zelis R, Salel AF.
    Chest; 1973 Oct 17; 64(4):486-90. PubMed ID: 4355275
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J, Sezille G, Dewailly P, Fruchart JC.
    Diabete Metab; 1977 Sep 17; 3(3):159-64. PubMed ID: 199484
    [Abstract] [Full Text] [Related]

  • 13. [Effect of partial ileoshunting on hyperlipoproteinemia in patients with atherosclerosis].
    Sedletskiĭ IuI.
    Vestn Khir Im I I Grek; 1985 Aug 17; 135(8):48-51. PubMed ID: 4060509
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyperlipidaemia and the pathogenesis of atherosclerosis.
    Walton KW.
    Adv Drug Res; 1974 Aug 17; 9():55-67. PubMed ID: 4377199
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The dyslipoproteinemias.
    Brown DF.
    Acta Diabetol Lat; 1972 Dec 17; 9 Suppl 2():18-52. PubMed ID: 4369284
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.